Ilaria Catalano

Director de Operaciones en MSD Italia Srl .

Health Technology

Perfil

Ilaria Catalano has worked at MSD Italia Srl since 2008.
Her current job title is Executive Director-Business Operations, which she started in 2013.

Cargos activos de Ilaria Catalano

Empresas	Cargo	Inicio
MSD Italia Srl MSD Italia Srl Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.	Director de Operaciones	01/01/2013

Todos los cargos activos de Ilaria Catalano

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ilaria Catalano.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
MSD Italia Srl MSD Italia Srl Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.	Health Technology